These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2874227)
41. Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig. Booze RM; Crisostomo EA; Davis JN J Pharmacol Exp Ther; 1989 Jun; 249(3):911-20. PubMed ID: 2567353 [TBL] [Abstract][Full Text] [Related]
42. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. Neve KA; Barrett DA; Molinoff PB J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205 [TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. Neve KA; McGonigle P; Molinoff PB J Pharmacol Exp Ther; 1986 Jul; 238(1):46-53. PubMed ID: 3014123 [TBL] [Abstract][Full Text] [Related]
44. Biphasic binding of 125I-iodocyanopindolol to beta-adrenergic receptors in rat cerebral cortical membranes. I. Assessment by the use of agonists. Tsuchihashi H; Nagatomo T Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2966-72. PubMed ID: 2890440 [No Abstract] [Full Text] [Related]
45. Serotonergic neurons do not influence the regulation of beta adrenoceptors induced by either desipramine or isoproterenol. Hensler JG; Ordway GA; Gambarana C; Areso P; Frazer A J Pharmacol Exp Ther; 1991 Feb; 256(2):656-64. PubMed ID: 1847207 [TBL] [Abstract][Full Text] [Related]
46. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. McGonigle P; Neve KA; Molinoff PB Mol Pharmacol; 1986 Oct; 30(4):329-37. PubMed ID: 2876374 [TBL] [Abstract][Full Text] [Related]
48. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. Hoyer D; Engel G; Kalkman HO Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805 [TBL] [Abstract][Full Text] [Related]
49. Cell-based beta2-adrenergic receptor-ligand binding assay using synthesized europium-labeled ligands and time-resolved fluorescence. Martikkala E; Lehmusto M; Lilja M; Rozwandowicz-Jansen A; Lunden J; Tomohiro T; Hänninen P; Petäjä-Repo U; Härmä H Anal Biochem; 2009 Sep; 392(2):103-9. PubMed ID: 19464246 [TBL] [Abstract][Full Text] [Related]
50. Synthesis of new 1-(amino)-3-[(1,5-diphenyl-1H-1,2,4-triazol-3-yl) oxy] propan-2-ol and 1-[(1,5-diphenyl- 1H- 1,2,4-triazol-3-yl) oxy]-3-(4-arylpiperazin-1-yl) propan-2-ol derivatives with an expected beta-adrenolytic activity. Kossakowski J; Struga M; Kozioł AE Acta Pol Pharm; 2006; 63(4):255-9. PubMed ID: 17203860 [TBL] [Abstract][Full Text] [Related]
51. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts. Bjørnerheim R; Golf S; Hansson V Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020 [TBL] [Abstract][Full Text] [Related]
52. A beta adrenoceptor with atypical characteristics is involved in the relaxation of the rat small intestine. van der Vliet A; Rademaker B; Bast A J Pharmacol Exp Ther; 1990 Oct; 255(1):218-26. PubMed ID: 1976798 [TBL] [Abstract][Full Text] [Related]
53. Effects of clenbuterol and antidepressant drugs on beta adrenergic receptor/N-protein coupling in the cerebral cortex of the rat. O'Donnell JM; Frazer A J Pharmacol Exp Ther; 1985 Jul; 234(1):30-6. PubMed ID: 2989510 [TBL] [Abstract][Full Text] [Related]
54. N-Bromoacetyl-amino-cyanopindolol: a highly potent beta-adrenergic affinity label blocks irreversibly a non-protein component tightly associated with the receptor. Chorev M; Feigenbaum A; Keenan AK; Gilon C; Levitzki A Eur J Biochem; 1985 Jan; 146(1):9-14. PubMed ID: 2981685 [TBL] [Abstract][Full Text] [Related]
55. Guanine nucleotides modulate the affinity of antagonists at beta-adrenergic receptors. Wolfe BB; Harden TK J Cyclic Nucleotide Res; 1981; 7(5):303-12. PubMed ID: 6124564 [TBL] [Abstract][Full Text] [Related]
56. Effects of choline and inositol on 3H-dihydroalprenolol and 125I-iodocyanopindolol bindings to beta-adrenergic receptors of the guinea pig cerebral cortical membranes. Tsuchihashi H; Nagatomo T Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):360-6. PubMed ID: 2837340 [No Abstract] [Full Text] [Related]
57. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Weiland GA; Minneman KP; Molinoff PB Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167 [No Abstract] [Full Text] [Related]
58. Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors. Willcocks AL; Nahorski SR Biochem Pharmacol; 1983 Nov; 32(22):3311-9. PubMed ID: 6316978 [TBL] [Abstract][Full Text] [Related]
59. Binding of [125I]iodocyanopindolol by rat harderian gland crude membranes: kinetic characteristics and day-night variations. Harmouch A; Osuna C; Rafii-el-Idrissi M; Calvo JR; Guerrero JM Biosci Rep; 1996 Oct; 16(5):369-77. PubMed ID: 8913527 [TBL] [Abstract][Full Text] [Related]
60. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors. Fabisiak JP; Vesell ES; Rannels DE J Pharmacol Exp Ther; 1987 May; 241(2):722-7. PubMed ID: 2883305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]